Dr. Gu is the Vice Chairman and President of XPeng Inc. (NYSE: XPEV, HKEX: 9868), a leading smart electric vehicle company in China. His main areas of responsibility at XPeng include strategy, finance, legal, investments, and globalization efforts. Since joining XPeng in 2018, Dr. Gu has successfully led many landmark capital raising activities for the company, totaling over $6.5 billion. These have included Xpeng’s listing debut on the New York Stock Exchange in 2020, raising $1.7 billion in one of 2020’s most successful US IPOs for a Chinese company, and the subsequent $2.5 billion follow-on issuance, the largest ever first-time follow-on ADS offering by a Chinese company, and its successful dual-primary listing at the Hong Kong Stock Exchange in July 2021, raising about $2 billion in less than a year since the company’s NYSE debut.
Prior to joining Xpeng, Dr. Gu was a managing director, Chairman of Asia Pacific Investment Banking and a member of the Global Strategic Advisory Council at J.P. Morgan, and was instrumental in building J.P. Morgan’s franchise in the Asia Pacific region. Between 1998-2004, Dr. Gu worked in the global M&A and global healthcare practice of Lehman Brothers in New York. During his 20-year investment banking career, Dr. Gu has advised numerous global leading companies on their strategy and landmark transactions, totaling over $200 billion in transaction volume.
Prior to his Wall Street career, Dr. Gu was a senior research scientist at the University of Washington Medical School. Dr. Gu is a member of the Greater China Advisory Committee of Yale School of Management, as well as a trustee of Yale China Association.
Dr. Gu holds an MBA from Yale University, a Ph.D. in Biochemistry from the University of Washington Medical School, and a bachelor degree in Chemistry from the University of Oregon.